December 4, 2022

Bionpa

You are Your Only Limit

Fzata Winner of Mid-Atlantic Innovation Celebration, Biotechnology · BioBuzz

2 min read

HALETHORPE, Md., May 20, 2022 /PRNewswire/ — Fzata, Inc., a biotech innovator, is proud to announce that it has been named the winner of the 2022 Mid-Atlantic Innovation Celebration for Biotechnology for its oral Bioengineered Probiotic Yeast Medicines (BioPYM™) platform. The Company is honored to have been picked for this award from among so numerous extremely progressive rivals.

Each and every 12 months the celebration, hosted by Northern Virginia Chamber of Commerce (NOVA) and BigIdea ConnectPreneur, showcases the region’s finest and most imaginative minds at operate. Innovators can be just about everything, from reducing-edge solutions that clear up business enterprise needs to imaginative shifts that boost personnel morale. 

Fzata is a in close proximity to-medical phase platform biopharmaceutical corporation in the BioHealth Cash Area. Our vision is to lower health inequities by expanding individual entry to therapeutic biologics with patient friendly oral capsules. BioPYM makes use of genetically modified live yeast as a ‘micro-factory’ to make recombinant biologics in the gut to goal disease biomarkers and modulate intestine operate. A to start with-in-human clinical analyze for Clostridioides difficile infection is qualified for 1Q2023. BioPYM positive aspects consist of: simple producing, no cold-chain, no infusions or injections and a “bottomless” pipeline for gastro-intestinal ailments and related ailments. Fzata’s innovation is supported by NIH with over $17M in non-dilutive funding. Fzata is now raising $10M to support the inflammatory bowel sickness (IBD) BioPYM system through phase 1 medical demo.

Dr. Zhiyong Yang, President and CEO of Fzata, commented, “Fzata’s eyesight of growing patient access to therapeutic biologics is only designed possible with our scientific improvements. Innovation underneath-pins our ground-breaking BioPYM system and its many aggressive benefits. Patient-pleasant BioPYM will enable oral options for injectable biologics like Humira® and Remicade®. Innovation has additional enhanced BioPYM so that it can be utilised to categorical any biologic therapeutic to handle gastrointestinal ailments like bacterial infections, inflammation, cancer, and diabetic issues as perfectly as gut axis conditions.”

About Fzata
Fzata (www.Fzata.com) is a in the vicinity of-medical phase biopharmaceutical business, establishing oral are living biologic-based mostly preventive and therapeutic medications. The Corporation owns two proprietary platforms: one particular to make entirely humanized multi-specific antibodies and a 2nd, BioPYM, for localized shipping and delivery of recombinant biologic therapeutics to take care of gastrointestinal similar illnesses.

About Northern Virginia Chamber of Commerce 
Started in 1925 as a Fairfax County-focused company advocacy corporation, NOVA is the region’s major Chamber of Commerce, drawing associates and impacting policy across the Greater Washington D.C. Metropolitan Area.

Get hold of: Dr. Elizabeth Smith PhD, [email protected]

bionpa.com All rights reserved. | Newsphere by AF themes.